Skip to main content
. 2017 Mar 8;7:44043. doi: 10.1038/srep44043

Figure 1. MCP-1 and sSiglec-9 are essential for SHED-CM-mediated M2 induction and recovery from ALF.

Figure 1

(a) Experimental design. D-Gal, D-galactosamine; CM, conditioned medium; MCP-1, monocyte chemoattractant protein-1; sSiglec-9, secreted ectodomain of sialic acid-binding Ig-like lectin-9; i.v., intravenous injection; i.p., intraperitoneal injection. (b) Kaplan–Meier survival analysis of SHED-CM, dSHED-CM, and DMEM treatment groups. The log rank test was used to compare the SHED-CM (n = 11) and dSHED-CM (n = 10) groups (P = 0.002), and the SHED-CM and DMEM (n = 10) groups (P = 0.002). ∗∗P < 0.01. (c) Representative images of HE-stained livers. Scale bar: 100 μm. Pre, pre-treatment. (d) Levels of the indicated mRNAs in the livers of CM-treated rats. Results are expressed relative to the level in the sham-operated model. Data represent the mean ± standard error of the mean (SEM) (n = 4 per group); ∗P < 0.05.